These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17985858)

  • 21. Evaluation of bisbenzamidines as inhibitors for matriptase-2.
    Beckmann AM; Gilberg E; Gattner S; Huang TL; Vanden Eynde JJ; Mayence A; Bajorath J; Stirnberg M; Gütschow M
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3741-5. PubMed ID: 27287367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modification of the N-terminal sulfonyl residue in 3-amidinophenylalanine-based matriptase inhibitors.
    Steinmetzer T; Dönnecke D; Korsonewski M; Neuwirth C; Steinmetzer P; Schulze A; Saupe SM; Schweinitz A
    Bioorg Med Chem Lett; 2009 Jan; 19(1):67-73. PubMed ID: 19036586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of serine proteinase inhibitors by combinatorial chemistry using trypsin inhibitor SFTI-1 as a starting structure.
    Zabłotna E; Jaśkiewicz A; Łegowska A; Miecznikowska H; Lesner A; Rolka K
    J Pept Sci; 2007 Nov; 13(11):749-55. PubMed ID: 17828796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary amides of sulfonylated 3-amidinophenylalanine. New potent and selective inhibitors of matriptase.
    Steinmetzer T; Schweinitz A; Stürzebecher A; Dönnecke D; Uhland K; Schuster O; Steinmetzer P; Müller F; Friedrich R; Than ME; Bode W; Stürzebecher J
    J Med Chem; 2006 Jul; 49(14):4116-26. PubMed ID: 16821772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implication of the disulfide bridge in trypsin inhibitor SFTI-1 in its interaction with serine proteinases.
    Lęgowska A; Dębowski D; Lukajtis R; Wysocka M; Czaplewski C; Lesner A; Rolka K
    Bioorg Med Chem; 2010 Dec; 18(23):8188-93. PubMed ID: 21036622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete substitutional analysis of a sunflower trypsin inhibitor with different serine proteases.
    Hilpert K; Hansen G; Wessner H; Volkmer-Engert R; Höhne W
    J Biochem; 2005 Oct; 138(4):383-90. PubMed ID: 16272132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineering inhibitors highly selective for the S1 sites of Ser190 trypsin-like serine protease drug targets.
    Katz BA; Sprengeler PA; Luong C; Verner E; Elrod K; Kirtley M; Janc J; Spencer JR; Breitenbucher JG; Hui H; McGee D; Allen D; Martelli A; Mackman RL
    Chem Biol; 2001 Nov; 8(11):1107-21. PubMed ID: 11731301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sunflower Trypsin Inhibitor-1 (SFTI-1): Sowing Seeds in the Fields of Chemistry and Biology.
    de Veer SJ; White AM; Craik DJ
    Angew Chem Int Ed Engl; 2021 Apr; 60(15):8050-8071. PubMed ID: 32621554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recruiting Zn2+ to mediate potent, specific inhibition of serine proteases.
    Katz BA; Luong C
    J Mol Biol; 1999 Sep; 292(3):669-84. PubMed ID: 10497030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sunflower trypsin inhibitor-1, proteolytic studies on a trypsin inhibitor peptide and its analogs.
    Colgrave ML; Korsinczky MJ; Clark RJ; Foley F; Craik DJ
    Biopolymers; 2010; 94(5):665-72. PubMed ID: 20564016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. α-Ketobenzothiazole Serine Protease Inhibitors of Aberrant HGF/c-MET and MSP/RON Kinase Pathway Signaling in Cancer.
    Han Z; Harris PK; Karmakar P; Kim T; Owusu BY; Wildman SA; Klampfer L; Janetka JW
    ChemMedChem; 2016 Mar; 11(6):585-99. PubMed ID: 26889658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphono Bisbenzguanidines as Irreversible Dipeptidomimetic Inhibitors and Activity-Based Probes of Matriptase-2.
    Häußler D; Mangold M; Furtmann N; Braune A; Blaut M; Bajorath J; Stirnberg M; Gütschow M
    Chemistry; 2016 Jun; 22(25):8525-35. PubMed ID: 27214780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical synthesis and kinetic study of the smallest naturally occurring trypsin inhibitor SFTI-1 isolated from sunflower seeds and its analogues.
    Zabłotna E; Kaźmierczak K; Jaśkiewicz A; Stawikowski M; Kupryszewski G; Rolka K
    Biochem Biophys Res Commun; 2002 Apr; 292(4):855-9. PubMed ID: 11944892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KLK4 Inhibition by Cyclic and Acyclic Peptides: Structural and Dynamical Insights into Standard-Mechanism Protease Inhibitors.
    Riley BT; Ilyichova O; de Veer SJ; Swedberg JE; Wilson E; Hoke DE; Harris JM; Buckle AM
    Biochemistry; 2019 May; 58(21):2524-2533. PubMed ID: 31058493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzymatic cyclization of a potent bowman-birk protease inhibitor, sunflower trypsin inhibitor-1, and solution structure of an acyclic precursor peptide.
    Marx UC; Korsinczky ML; Schirra HJ; Jones A; Condie B; Otvos L; Craik DJ
    J Biol Chem; 2003 Jun; 278(24):21782-9. PubMed ID: 12621047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limiting the Number of Potential Binding Modes by Introducing Symmetry into Ligands: Structure-Based Design of Inhibitors for Trypsin-Like Serine Proteases.
    Furtmann N; Häußler D; Scheidt T; Stirnberg M; Steinmetzer T; Bajorath J; Gütschow M
    Chemistry; 2016 Jan; 22(2):610-25. PubMed ID: 26625703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and analysis of novel bicyclic and bifunctional protease inhibitors.
    Jaulent AM; Leatherbarrow RJ
    Protein Eng Des Sel; 2004 Sep; 17(9):681-7. PubMed ID: 15486024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design of Potent and Selective Cathepsin G Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold.
    Swedberg JE; Li CY; de Veer SJ; Wang CK; Craik DJ
    J Med Chem; 2017 Jan; 60(2):658-667. PubMed ID: 28045523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factor VIIa inhibitors: target hopping in the serine protease family using X-ray structure determination.
    Shiraishi T; Kadono S; Haramura M; Kodama H; Ono Y; Iikura H; Esaki T; Koga T; Hattori K; Watanabe Y; Sakamoto A; Yoshihashi K; Kitazawa T; Esaki K; Ohta M; Sato H; Kozono T
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4533-7. PubMed ID: 18674905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changing the selectivity profile - from substrate analog inhibitors of thrombin and factor Xa to potent matriptase inhibitors.
    Maiwald A; Hammami M; Wagner S; Heine A; Klebe G; Steinmetzer T
    J Enzyme Inhib Med Chem; 2016; 31(sup1):89-97. PubMed ID: 27168215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.